Page last updated: 2024-11-03

probucol and Hearing Loss, Sensorineural

probucol has been researched along with Hearing Loss, Sensorineural in 1 studies

Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.

Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wagle, SR1
Ionescu, CM1
Kovacevic, B1
Jones, M1
Foster, T1
Lim, P1
Lewkowicz, M1
Ðanić, M1
Mikov, M1
Mooranian, A1
Al-Salami, H1

Other Studies

1 other study available for probucol and Hearing Loss, Sensorineural

ArticleYear
Pharmaceutical characterization of probucol bile acid-lithocholic acid nanoparticles to prevent chronic hearing related and similar cellular oxidative stress pathologies.
    Nanomedicine (London, England), 2023, Volume: 18, Issue:12

    Topics: Antioxidants; Bile Acids and Salts; Hearing; Hearing Loss, Sensorineural; Humans; Nanoparticles; Oxi

2023